ACA

CAS No. 110683-10-8

ACA( N-(p-amylcinnamoyl) Anthranilic Acid )

Catalog No. M20201 CAS No. 110683-10-8

N-(p-amylcinnamoyl) Anthranilic Acid (ACA) is a broad spectrum Phospholipase A2 (PLA2) inhibitor and TRP channel blocker.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
25MG 37 In Stock
50MG 59 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ACA
  • Note
    Research use only, not for human use.
  • Brief Description
    N-(p-amylcinnamoyl) Anthranilic Acid (ACA) is a broad spectrum Phospholipase A2 (PLA2) inhibitor and TRP channel blocker.
  • Description
    N-(p-amylcinnamoyl) Anthranilic Acid (ACA) is a broad spectrum Phospholipase A2 (PLA2) inhibitor and TRP channel blocker.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    N-(p-amylcinnamoyl) Anthranilic Acid
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phospholipase
  • Recptor
    PLA2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    110683-10-8
  • Formula Weight
    337.42
  • Molecular Formula
    C21H23NO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (370.47 mM);Water:Insoluble
  • SMILES
    CCCCCc1ccc(\C=C\C(=O)Nc2ccccc2C(O)=O)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kraft R et al. Inhibition of TRPM2 cation channels by N-(p-amylcinnamoyl)anthranilic acid. Br J Pharmacol. 2006 Jun;148(3):264-73.
molnova catalog
related products
  • D-Erythro-dihydrosph...

    D-Erythro-dihydrosphingosine inhibits arachidonic acid release and cPLA2α activity.

  • CCT129957

    CCT129957 is a novel and potent phospholipase C-γ (PLC-γ) inhibitor with an IC50 of about 3 μM and a GC50 of 15 μM.CCT129957 exhibits anticancer activity and inhibits Ca2+ release in squamous cells.

  • Lp-PLA2-IN-3

    Lp-PLA2-IN-3 is a potent, orally bioactive lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, effectively inhibiting recombinant human [Lp-PLA2] with an IC50 value of 14 nM.